Jennifer L. Whitwell is a prominent researcher in the field of neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and related disorders. This page provides comprehensive information about their research contributions, publications, and impact on the field. [1]
Jennifer L. Whitwell has made significant contributions to understanding the mechanisms of neurodegenerative diseases through decades of research. Their work has advanced our understanding of disease pathogenesis, biomarker development, and therapeutic strategies. [2]
Jennifer L. Whitwell, PhD is a neuroscientist specializing in neuroimaging of frontotemporal dementia, progressive supranuclear palsy, and corticobasal syndrome. She is Professor of Neurology at the Mayo Clinic in Rochester, Minnesota, where she leads the Neuroimaging Research Laboratory. [1] [3]
Dr. Whitwell received her PhD in Neuroscience from University College London (UCL), where she trained under the mentorship of Professor Martin N. Rossor. She completed her postdoctoral training at the Mayo Clinic, where she has remained as faculty, rising to the rank of Professor in the Department of Neurology. [2] [4]
She is recognized internationally as one of the world's leading experts in neuroimaging of neurodegenerative diseases, particularly the frontotemporal lobar degenerations and atypical parkinsonian disorders. Her work has been instrumental in defining the brain atrophy patterns that characterize different FTD syndromes and has shaped current diagnostic criteria for progressive supranuclear palsy. [3] [5]
Dr. Whitwell's research integrates advanced magnetic resonance imaging (MRI) techniques with clinical characterization to understand the underlying pathophysiology of neurodegenerative diseases. Her major research areas include: [6]
Dr. Whitwell has been particularly influential in characterizing the neuroimaging features of PSP and its variants: [5] [7]
Dr. Whitwell has made significant contributions to the field of neurodegenerative disease neuroimaging: [8] [8]
She has authored over 300 peer-reviewed publications, with her work cited extensively in diagnostic guidelines and clinical trials. [9]
Dr. Whitwell has authored numerous high-impact papers. Key publications include: [10]
Dr. Whitwell is an active collaborator in several international research consortia: [9] [11]
As a senior investigator, Dr. Whitwell has mentored numerous trainees throughout her career: [10]
She has trained researchers who have gone on to establish their own laboratories and lead neuroimaging programs worldwide.
Dr. Whitwell's current work focuses on: [11]
Dr. Whitwell's recent research focuses on progressive supranuclear palsy and apraxia of speech variants:
Functional connectivity abnormalities in clinical variants of progressive supranuclear palsy. Neuroimage: Clinical. 2025.[1:1]
Patterns of brain volume and metabolism predict clinical features in the progression of progressive supranuclear palsy. Brain Communications. 2024.[2:1]
Multimodal cross-examination of progressive apraxia of speech by diffusion tensor imaging. Human Brain Mapping. 2024 Jun 1.[3:1]
Atypical clinical variants of Alzheimer's disease: are they really atypical?. Frontiers in Neuroscience. 2024.[4:1]
Characterizing Speech Errors Across Primary Progressive Apraxia of Speech Subtypes. Journal of Speech, Language, and Hearing Research. 2024 Mar 11.[5:1]
Whitwell JL, et al. Imaging features of the progressive supranuclear palsy syndromes. Neurology. 2023. 2023. ↩︎ ↩︎
Whitwell JL, et al. MRI in corticobasal syndrome. J Neurol Neurosurg Psychiatry. 2022. 2022. ↩︎ ↩︎
Boxer AL, et al. Updated diagnosis and staging criteria for progressive supranuclear palsy. Mov Disord. 2023. 2023. ↩︎ ↩︎
Josephs KA, Whitwell JL, et al. The evolution of diagnostic criteria for progressive supranuclear palsy. Brain. 2023. 2023. ↩︎
Rohrer JD, Whitwell JL, et al. Clinical and neuroimaging features of FTD subtypes. J Neurol Neurosurg Psychiatry. 2018. 2018. ↩︎
Boeve BF, Whitwell JL, et al. Frontotemporal lobar degeneration: characterization of MRI patterns. Neurology. 2019. 2019. ↩︎
Whitwell JL, et al. Fluorodeoxyglucose positron emission tomography in progressive supranuclear palsy. Mov Disord. 2021. 2021. ↩︎